Marinol from AbbVie: What Is It and Who Are They

A description of what Marional is and who AbbVie are

Image Credit: Oleksii Mishchenko on Shutterstock

Some of the most daunting health challenges of our time have a low-survival rate and a deadly cultural significance. Two of these illnesses are AIDS and cancer. AbbVie has set out to look past tragedy in order to bring comfort to these patients

Who are AbbVie?
AbbVie is a global company–with international staff and a range of national sites. They see themselves as a company that takes on the largest health crises of our time. They focus on life-threatening illnesses and chronic conditions. They claim to use new solutions to target to challenging to cure diseases, where they use their resources and their research and develop team to advance medicine and science.

AbbVie asserts they want to have more impact than treating illnesses. They want to have a positive impact on “patients’ lives, on societies, and on science itself.”

What is Marinol?
Marinol (dronabinol) is a controlled substance (schedule III) because it contains dronabinol. Dronabinol can be a target for people who abuse street drugs, according to AbbVie. Therefore, they warn to keep the medicine secure from theft and that selling the product is a crime. The risk of giving someone else your Marinol is high.

Dronabinol is a synthetic, lab made delta-9-tetrahydrocannabinol (delta-9-THC). As Dronabinol is built off the functions and molecules of THC, it is a cannabinoid from the cannabis plant that impacts the endocannabinoid system. The benefits of Marinol are that is is legal no matter state and medical marijuana is not. However, the side effects of medical marijuana are low-risk while marinol can easily be deadly if not monitored.

Marinol comes with a large list of side effects. The medicine can impact your mood and concentration. It can also increase sleepiness and confusion. Marinol may cause changes in blood pressure, particularly when the patients stand up. The medicine may cause headaches, vision problems, dizziness, feeling light-headed, fainting, irritability, nervousness, restlessness, nausea, vomiting, abdominal pain, or a fast heartbeat. It may also increase risk of seizures.

If you have Mania, Depression, or Schizophrenia, Marinol can worsen theses psychiatric symptoms. AbbVie also warns Marinol is not for those with a history of drug abuse or dependence, including alcohol. It is addictive and appealing to drug addicts. If one has abused drugs or alcohol in the past, they’re not recommended to use Marinol. You can also not take Marinol if you’re allergic to either dronabinol or sesame oil.

An allergic reaction will come with the signs or symptoms of skin burning, flushing, and throat tightness. If you have a reaction to the dronabinol found in Marinol, you should seek out medical care. AbbVie in not responsible or so they declare in the small print. While on Marinol, you’re not allowed to operate machinery as it has sedative and psychoactive effects.

If you are at risk with the effects of Marinol, your doctor will not prescribe it so long as they are updated on your current ailments and medication. Marinol is available as 2.5mg, 5mg, or 10mg gelatin capsules.

What is Marinol for?
Marinol is used in two medical cases. One is the treatment of loss of appetite in people with AIDS (Acquired Immune Deficiency Syndrome) who have lost weight. The second treatment clause is nausea and vomiting caused by chemotherapy (anti-cancer medicine) in patients whose nausea and vomiting have not improved with traditional anti-nausea medications.

The doctor will likely start patients suffering from AIDS at 2.5 mg twice daily. The doctor will then adjust dosage after seeing how the patient is impacted. Elderly patients may be prescribed only one 2.5mg tablet a day.

For Chemotherapy, the doctor will determine the dose. The dose might be between about 4 or 6 per day, and are taken before and after chemotherapy. If the patient is elderly, the doctor may only prescribe Marinol once a day 1-3 hours before chemotherapy. The lower dose for both ailments is to reduce the likelihood of nervous system problems.

Jonathan Neilly
Jonathan Neilly
Jonathan Neilly is registered with the British Psychological Society, breaking the taboo on mental health issues is one of the driving forces in his life. His background in biomedicine gives him additional understanding of the factors that work together to influence the human condition.

Leave a Reply

Your email address will not be published. Required fields are marked *